Is PABCX or JNJ a better dividend investment in 2026?

PABCX currently yields 8.61% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: PABCX offers higher current income.

What is the dividend yield difference between PABCX and JNJ?

PABCX has a forward dividend yield of 8.61% ($1.56/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 5.25 percentage points.

Home › Compare › PABCX vs JNJ

PABCX vs JNJ: Dividend Comparison 2026

PABCX yields 8.61% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PABCX wins by $15.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

PABCX

● Live price

8.61%

Share price

$18.11

Annual div

$1.56

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$35.4K

Annual income

$1,484.00

Full PABCX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — PABCX vs JNJ

📍 PABCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PABCX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PABCX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PABCX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PABCX

Annual income on $10K today (after 15% tax)

$732.18/yr

After 10yr DRIP, annual income (after tax)

$1,261.40/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, PABCX beats the other by $557.79/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PABCX + JNJ for your $10,000?

PABCX: 50%JNJ: 50%

100% JNJ50/50100% PABCX

Portfolio after 10yr

$27.7K

Annual income

$1,155.89/yr

Blended yield

4.17%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PABCX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PABCX buys

JNJ buys

No recent congressional trades found for PABCX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPABCXJNJ

Forward yield	8.61% ✓	3.36%
Annual dividend / share	$1.56	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$35.4K ✓	$20.0K
Annual income after 10y	$1,484.00 ✓	$827.78
Total dividends collected	$11.8K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: PABCX vs JNJ ($10,000, DRIP)

Year	PABCX Portfolio	PABCX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,561	$861.39	$10,676	$355.77	+$885.00 → PABCX
2	$13,301	$930.74	$11,407	$389.39	+$1.9K → PABCX
3	$15,233	$1,000.76	$12,198	$426.53	+$3.0K → PABCX
4	$17,371	$1,071.13	$13,056	$467.62	+$4.3K → PABCX
5	$19,728	$1,141.52	$13,987	$513.12	+$5.7K → PABCX
6	$22,321	$1,211.63	$14,998	$563.56	+$7.3K → PABCX
7	$25,164	$1,281.17	$16,098	$619.52	+$9.1K → PABCX
8	$28,276	$1,349.90	$17,295	$681.69	+$11.0K → PABCX
9	$31,673	$1,417.58	$18,599	$750.82	+$13.1K → PABCX
10	$35,374	$1,484.00	$20,022	$827.78	+$15.4K → PABCX

PABCX vs JNJ: Complete Analysis 2026

PABCX — Stock

The investment seeks income and long-term growth of capital. The fund invests in a portfolio of equity, fixed-income and money market securities that is actively managed to capitalize on opportunities created by perceived misvaluation. It will invest 45% to 70% of its total assets in equity and equity-related securities. Under normal circumstances, 30% to 55% of the fund's total assets are invested in fixed income securities. It may invest up to 15% of its total assets in equity-related securities of small companies.

Full PABCX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this PABCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PABCX vs SCHD PABCX vs JEPI PABCX vs O PABCX vs KO PABCX vs MAIN PABCX vs ABBV PABCX vs MRK PABCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.